Corrigendum to “Design, synthesis, and biological evaluation of cathepsin B cleavage albumin-binding SN38 prodrug in breast cancer” [Bioorg. Chem. 147 (2024) 107370]
Bioorganic Chemistry · 2026-11 · 183 · 110573
DOI: 10.1016/j.bioorg.2026.110573 ↗Kurz gefasst
Korrektur in der Zeitschrift Bioorganic Chemistry, 2026-11. Verfasst von Yingxin Lu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China No….
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, 3663 North Zhongshan Road, Shanghai 200062, PR China.
- Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, 3663 North Zhongshan Road, Shanghai 200062, PR China.…
- Innovation Center for AI and Drug Discovery, East China Normal University, 3663 North Zhongshan Road, Shanghai 200062, PR China. Electronic address: slzhu@chem.ecnu.edu.cn.
Zitieren
APA
Lu, Y., Huang, Y., Jin, J., Yu, J., Lu, W., & Zhu, S. (2026). Corrigendum to “Design, synthesis, and biological evaluation of cathepsin B cleavage albumin-binding SN38 prodrug in breast cancer” [Bioorg. Chem. 147 (2024) 107370]. Bioorganic Chemistry, 183, 110573. https://doi.org/10.1016/j.bioorg.2026.110573
Vancouver
Lu Y, Huang Y, Jin J, Yu J, Lu W, Zhu S. Corrigendum to “Design, synthesis, and biological evaluation of cathepsin B cleavage albumin-binding SN38 prodrug in breast cancer” [Bioorg. Chem. 147 (2024) 107370]. Bioorganic Chemistry. 2026;183:110573. doi:10.1016/j.bioorg.2026.110573
BibTeX
@article{Lu2026,
author = {Lu, Yingxin and Huang, Ying and Jin, Jiyu and Yu, Jiahui and Lu, Wei and Zhu, Shulei},
title = {Corrigendum to “Design, synthesis, and biological evaluation of cathepsin B cleavage albumin-binding SN38 prodrug in breast cancer” [Bioorg. Chem. 147 (2024) 107370]},
journal = {Bioorganic Chemistry},
year = {2026},
volume = {183},
pages = {110573},
doi = {10.1016/j.bioorg.2026.110573}
}
EUVIMED